Avalon Ventures Newswire

Avalon Ventures Newswire

Comprehensive Real-Time News Feed for Avalon Ventures.

Results 1 - 20 of 44 in Avalon Ventures

  1. Avelas Biosciences Completes $20 Million Series C FinancingRead the original story

    Wednesday Aug 17 | Venture Capital Access Online

    ... includes new investors Ervington Investments Limited and Alexandria Venture Investments. Existing investors Avalon Ventures, Bregua Corporation, and WuXi Healthcare Ventures participated in the financing as well. Avelas Biosciences plans to use the ...

    Comment?

  2. Avelas Biosciences Raises $20MRead the original story

    Thursday Aug 18 | SocalTECH.com

    San Diego-based biopharmaceuticals developer Avelas Biosciences has raised $20M in a Series C funding, according to the company. The new funding was led by Pharmstandard International, S.A., and laos included Ervington Investments Limited and Alexandria Venture Investments plus Avalon Ventures, Bregua Corporation, and WuXi Healthcare Ventures.

    Comment?

  3. Introducing Redbooth for Apple TV, a Groundbreaking Productivity App...Read the original story w/Photo

    Thursday Aug 18 | Freshnews

    ... with development offices in Barcelona, Spain, Redbooth is privately held and funded by Altpoint Capital and Avalon Ventures. For more information and a free trial, visit Redbooth.com .

    Comment?

  4. Avelas Biosciences raises $20 mlnRead the original story

    Thursday Aug 18 | PE Hub

    Avelas Biosciences Inc said Aug 18 that it completed a $20 million Series C round of financing led by Pharmstandard International SA . New investors include Ervington Investments Ltd and Alexandria Venture Investments , while existing investors Avalon Ventures , Bregua Corp and WuXi Healthcare Ventures also participated in the financing.

    Comment?

  5. AeroFS to Showcase Amium, Industry's First Content-Centric...Read the original story w/Photo

    Monday Aug 8 | Freshnews

    ... eams. The company is headquartered in Palo Alto, California, and is funded by blue-chip investors, including Avalon Ventures, Andreessen Horowitz, and Y Combinator. Learn more about Amium at amium.com .

    Comment?

  6. -story-blockRead the original story w/Photo

    Jul 25, 2016 | The San Diego Union-Tribune

    ... The new financing, announced last week, was led by RA Capital Management and joined by earlier investors Avalon Ventures and Correlation Ventures. Turner is a partner in Avalon. In February, Synthorx had signed a partnership with an undisclosed ...

    Comment?

  7. AristaMD Gets $11M To Reduce Unnecessary Doctor's VisitsRead the original story

    Jul 22, 2016 | SocalTECH.com

    San Diego-based AristaMD , which is developing software tools to help coordinate referrals by physicians to specialists, has raised $11M in a Series A funding round. The funding was led by Avalon Ventures, and also included Correlation Ventures.

    Comment?

  8. AristaMD Secures $11 Million Series A FinancingRead the original story

    Jul 20, 2016 | Venture Capital Access Online

    AristaMD, a technology-enabled service company providing eConsults and a suite of related specialist referral support tools, announced today it completed $11 million in financing. The Series A round was led by Avalon Ventures with participation from Correlation Ventures.

    Comment?

  9. AristaMD secures $11 mln in Avalon-led Series ARead the original story

    Jul 21, 2016 | PE Hub

    AristaMD raised $11 million in a Series A round led by Avalon Ventures , with participation from Correlation Ventures . AristaMD is a digital health company that provides a platform for electronic consults and referrals.

    Comment?

  10. Synthorx Announces $10 Million Series B Financing to Develop and...Read the original story

    Jul 19, 2016 | Venture Capital Access Online

    Synthorx Inc. announced today the completion of a $10 million Series B financing, led by RA Capital Management and joined by Series A investors Avalon Ventures and Correlation Ventures. In conjunction with the financing, Andrew Levin, M.D., Ph.D., managing director of RA Capital Management, will join Synthorx's board of directors.

    Comment?

  11. Synthorx nabs $10 mln Series BRead the original story

    Jul 20, 2016 | PE Hub

    La Jolla, California-based Synthorx Inc , which uses synthetic biology to discover and develop new protein therapeutics, has closed $10 million in Series B financing. RA Capital Management led the round with participation from return backers Avalon Ventures and Correlation Ventures .

    Comment?

  12. Lithium is new resource in KenoraRead the original story w/Photo

    Jul 20, 2016 | Northern Ontario Business

    After mothballing its Separation Rapids lithium property for 15 years, Avalon Advanced Materials is taking a strong second look as the industrial metals price soars. With the price of the industrial metal going through the roof, the future demand for lithium has as much open-ended potential as Don Bubar's Separation Rapids project, near Kenora.

    Comment?

  13. Synthorx Raises $10MRead the original story

    Jul 20, 2016 | SocalTECH.com

    San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures.

    Comment?

  14. SoCal's Synthorx Bags 10 Million Series B FinancingRead the original story w/Photo

    Jul 19, 2016 | BioSpace

    Series B financing, led by RA Capital Management and joined by Series A investors Avalon Ventures and Correlation Ventures. In conjunction with the financing, Leveraging a synthetic biology breakthrough, Synthorx has developed scalable platforms for producing proteins that cannot be made through traditional methods.

    Comment?

  15. Redbooth Brings Powerful Task and Project Management to Cisco Spark Through New Bot...Read the original story w/Photo

    Jul 11, 2016 | Freshnews

    ... with development offices in Barcelona, Spain, Redbooth is privately held and funded by Altpoint Capital and Avalon Ventures. For more information and a free trial, visit Redbooth.com .

    Comment?

  16. Life sciences investor Lawrence Bock passes away at 56Read the original story

    Jul 11, 2016 | PE Hub

    Longtime venture capitalist and biotech entrepreneur Lawrence Bock , who co-founded Avalon Ventures in 1988, passed away at his home on July 6 after battling pancreatic cancer. He was 56. Bock, born Sept.

    Comment?

  17. -story-blockRead the original story w/Photo

    May 20, 2016 | The San Diego Union-Tribune

    ... team at COI Pharmaceuticals, Sitari and Silarus shows the potential of our collaboration with Avalon Ventures," said McDevitt, a GSK vice president of business development. The five other companies founded by the Avalon/GSK collaboration are ...

    Comment?

  18. Avalon Ventures and COI Pharmaceuticals Announce First Milestones for ...Read the original story

    May 20, 2016 | Freshnews

    Avalon Ventures and COI Pharmaceuticals, the Community Of Innovation established by Avalon, today announced that the first two companies formed under the collaboration with GlaxoSmithKline have achieved their first milestones. Sitari Pharmaceuticals, which is developing novel treatments for celiac disease, and Silarus Therapeutics, which is developing novel treatments for iron overload disorders, have both achieved lead declaration and established a path to identify a clinical candidate.

    Comment?

  19. Avalon Ventures: Startups Get Milestone Payments, New Company Launched With GSKRead the original story

    May 20, 2016 | SocalTECH.com

    San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration. Financial details of the milestone payments were not announced.

    Comment?

  20. Avelas Biosciences Announces Positive Interim Phase 1b Results and Advances to Dose Expansion StageRead the original story w/Photo

    May 9, 2016 | PR Newswire

    ... sing safety, pharmacokinetics and fluorescence properties using tissue image analysis. Avelas was founded by Avalon Ventures on technology from Nobel laureate

    Comment?